The Marino Medical Centre, Bantry, Co Cork study showed how RediCare Control in an Irish Primary Care setting is effective in treating Type 2 Diabetic, Pre-Diabetic, Hypertensive, Overweight and Obese patients.
Participants were reassured that the digital therapeutic was recommended by their G.P. and that their G.P. was available to support their treatment with medication adjustments, advice, and support as needed. The study showed that the therapeutic fitted smoothly within the GP workflow. This is now further enhanced as G.P's can now refer patients to the therapeutic electronically via 'Healthlink', the national e-referral system.
The high volume of recruitment (63 participants over a 6-month period by one Doctor) suggests that patients are more likely to partake in lifestyle therapy when a referral is made by their Doctor.
This work won a Paul Dudley Award from the American Heart Association.